Landos Biopharma Total Debt vs. Number Of Shares Shorted
Based on the key profitability measurements obtained from Landos Biopharma's financial statements, Landos Biopharma may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in April. Profitability indicators assess Landos Biopharma's ability to earn profits and add value for shareholders.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Please note, there is a significant difference between Landos Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Landos Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Landos Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
For Landos Biopharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Landos Biopharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Landos Biopharma utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Landos Biopharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Landos Biopharma over time as well as its relative position and ranking within its peers.
Landos |
Landos Biopharma Number Of Shares Shorted vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Landos Biopharma's current stock value. Our valuation model uses many indicators to compare Landos Biopharma value to that of its competitors to determine the firm's financial worth. Landos Biopharma is rated below average in total debt category among its peers. It also is rated below average in number of shares shorted category among its peers making about 0.05 of Number Of Shares Shorted per Total Debt. The ratio of Total Debt to Number Of Shares Shorted for Landos Biopharma is roughly 18.95 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Landos Biopharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Landos Total Debt vs. Competition
Landos Biopharma is rated below average in total debt category among its peers. Total debt of Health Care industry is now estimated at about 104.2 Million. Landos Biopharma adds roughly 27,000 in total debt claiming only tiny portion of equities under Health Care industry.
Landos Number Of Shares Shorted vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Landos Biopharma |
| = | 27 K |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Landos Biopharma |
| = | 1.43 K |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Landos Number Of Shares Shorted Comparison
Landos Biopharma is currently under evaluation in number of shares shorted category among its peers.
Landos Biopharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Landos Biopharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Landos Biopharma will eventually generate negative long term returns. The profitability progress is the general direction of Landos Biopharma's change in net profit over the period of time. It can combine multiple indicators of Landos Biopharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company was incorporated in 2017 and is headquartered in Blacksburg, Virginia. Landos Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 46 people.
Landos Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Landos Biopharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Landos Biopharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Landos Biopharma's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Landos Biopharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
All Next | Launch Module |
Use Investing Themes to Complement your Landos Biopharma position
In addition to having Landos Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Information Technology ETFs Thematic Idea Now
Information Technology ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Information Technology ETFs theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Information Technology ETFs Theme or any other thematic opportunities.
View All Next | Launch |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Landos Stock
If you are still planning to invest in Landos Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Landos Biopharma's history and understand the potential risks before investing.
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |